Updated Jan. 21, 2021
This interim guidance is based on what is currently known about the novel coronavirus (SARS-CoV-2) and coronavirus disease (COVID-19) as of the date of posting, December 1, 2020.
Guidance from the U.S. Centers for Disease Control and Prevention (CDC) are meant to supplement—not replace—any federal, state, local, territorial, or tribal health guidance. Implementation should be guided by what is feasible, practical, and acceptable, as well as tailored to the needs of each community or unique workplace environment. The intended audience is state, tribal, local, and territorial public health departments and their partners.
CDC will update this guidance as needed and as additional information becomes available.
Note: This document is intended to provide considerations for expanding screening testing for SARS-CoV-2, the virus that causes COVID-19 and does not dictate the determination of payment decisions or insurance coverage of such testing, except as may be otherwise referenced (or prescribed) by another entity or federal or state agency. CDC has no regulatory authority over testing; therefore, the information in this document is meant to assist health departments in making decisions rather than in establishing any regulatory requirements.
...
This interim guidance is based on what is currently known about the novel coronavirus (SARS-CoV-2) and coronavirus disease (COVID-19) as of the date of posting, December 1, 2020.
Guidance from the U.S. Centers for Disease Control and Prevention (CDC) are meant to supplement—not replace—any federal, state, local, territorial, or tribal health guidance. Implementation should be guided by what is feasible, practical, and acceptable, as well as tailored to the needs of each community or unique workplace environment. The intended audience is state, tribal, local, and territorial public health departments and their partners.
CDC will update this guidance as needed and as additional information becomes available.
Note: This document is intended to provide considerations for expanding screening testing for SARS-CoV-2, the virus that causes COVID-19 and does not dictate the determination of payment decisions or insurance coverage of such testing, except as may be otherwise referenced (or prescribed) by another entity or federal or state agency. CDC has no regulatory authority over testing; therefore, the information in this document is meant to assist health departments in making decisions rather than in establishing any regulatory requirements.
...
Comment